Systemic Sclerosis After Interferon Alphacon-1 Therapy for Hepatitis C

Internal Medicine - Japan
doi 10.2169/internalmedicine.46.6328
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Ocular Changes Due to Systemic Alpha-Interferon Therapy for Hepatitis C

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2004English

Two Cases Which Contracted New Diseases After About 1 Year of Interferon Therapy for Hepatitis C.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1995English

Favorable Prognosis of Chronic Hepatitis C After Interferon Therapy by Long-Term Cohort Study

Hepatology
MedicineHepatology
2003English

Usefulness of Two-Step Interferon Rebound Therapy for Refractory Chronic Hepatitis C.

Acta Hepatologica Japonica
Hepatology
2000English

Graves' Hyperthyroidism Showing Transient Hypothyroidism During Interferon Therapy for Chronic Hepatitis Type C

Endocrine Journal
EndocrinologyMetabolismDiabetes
2005English

A Long-Term Prognosis After Interferon Therapy for Chronic Hepatiti C.

Acta Hepatologica Japonica
Hepatology
1996English

Outcomes Research in Chronic Viral Hepatitis C: Effects of Interferon Therapy

Canadian Journal of Gastroenterology
2000English

Interferon Graft Dysfunction: A Final Chapter for Interferon and Hepatitis C

Hepatology International
Hepatology
2014English

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica
Hepatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy